How can the EU’s pharmaceutical legislation help tackle current challenges, including medicine shortages and antimicrobial resistance, across Europe? We put the question to Rainer Becker, Director for Medical Products and Innovation at DG SANTE.
Here, we find out about Yourgene Health, a molecular diagnostics company with products and technologies that enable precision medicine in oncology from bench to clinic.
After months of COVID, the psychological impact on staff emerges as a shadow pandemic - today (8 June), a Health Select Committee report finds that NHS "burnout is widespread reality".
Rick Clayton, Technical Director, AnimalhealthEurope, in the second chapter of this three-part series, continues to examine Benchmarking Regulatory systems governing veterinary medicines.
Nigel Shrive and David Hart from the McCaig Institute for Bone and Joint Health, University of Calgary, unravel the complexity of osteoarthritis and stress the need to integrate innovation in biomechanics, biology and imaging.
Senior Researcher in Social Science Michael Morrison explains why disruptive technologies need institutional and systemic readiness to truly realise the benefits of healthcare innovation.
A new study has revealed that new medicines and vaccines approved for use in the United States are often unavailable in countries that helped to develop them.
Robert Lembo, MD, Executive Director, Graduate Medical Education from the National Institutes of Health, turns the spotlight on training physician scientists and clinician investigators through the process of graduate medical education in the U.S.
Dr Shireen Kassam MBBS, FRCPath, PhD, dipIBLM, Founder and Director of Plant-Based Health Professionals UK, explains a simple prescription for health as a remedy to chronic disease.
Everard Munting, President of EUROSPINE, explains why sharing knowledge about spinal treatments on a global scale is the most effective way to develop best practice and enable early interventions.
Scientists at the University of Pittsburgh are creating COVID-19 antibodies in llamas, to understand how humans could engineer better immune responses.
